Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Journal of Public Health Management and Practice : JPHMP
|
July 27, 2011
Health ranking of the largest US counties using the Community Health Status Indicators peer strata and database
Norma Kanarek, Hua-Ling Tsai, Jennifer Stanley
British Journal of Haematology
|
August 5, 2024
Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Yosra M Aljawai, Hua-Ling Tsai, Ravi Varadhan, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Large Granular Lymphocytosis With Cytopenias After Allogeneic Blood or Marrow Transplantation: Clinical Characteristics and Response to Immunosuppressive Therapy
Marcus Messmer, Laura Wake, Hua-Ling Tsai, et al.
Blood Advances
|
May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age
Alexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.
Prostate Cancer and Prostatic Diseases
|
May 7, 2024
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Mayuko Kanayama, Hua-Ling Tsai, Hao Wang, et al.
Transplantation and Cellular Therapy
|
October 13, 2023
Allogeneic Hematopoietic Cell Transplantation with Non-Myeloablative Conditioning and Post-Transplant Cyclophosphamide Prophylaxis in Patients with Reduced Systolic Function
Frederick Ian LeMaistre, Hua-Ling Tsai, Ravi Varadhan, et al.
EJNMMI Research
|
May 22, 2016
Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma
Linda C Chu, Hua-Ling Tsai, Hao Wang, et al.
Cancer
|
December 7, 2018
The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status
Farhoud Faraji, Eleni M Rettig, Hua-Ling Tsai, et al.
Plos One
|
July 11, 2024
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer
Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, et al.
Oral Oncology
|
February 9, 2019
The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers
Margueritta El Asmar, Hua-Ling Tsai, Carole Fakhry, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Journal of Public Health Management and Practice : JPHMP
|
July 27, 2011
Health ranking of the largest US counties using the Community Health Status Indicators peer strata and database
Norma Kanarek, Hua-Ling Tsai, Jennifer Stanley
British Journal of Haematology
|
August 5, 2024
Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
Yosra M Aljawai, Hua-Ling Tsai, Ravi Varadhan, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Large Granular Lymphocytosis With Cytopenias After Allogeneic Blood or Marrow Transplantation: Clinical Characteristics and Response to Immunosuppressive Therapy
Marcus Messmer, Laura Wake, Hua-Ling Tsai, et al.
Blood Advances
|
May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age
Alexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.
Prostate Cancer and Prostatic Diseases
|
May 7, 2024
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Mayuko Kanayama, Hua-Ling Tsai, Hao Wang, et al.
Transplantation and Cellular Therapy
|
October 13, 2023
Allogeneic Hematopoietic Cell Transplantation with Non-Myeloablative Conditioning and Post-Transplant Cyclophosphamide Prophylaxis in Patients with Reduced Systolic Function
Frederick Ian LeMaistre, Hua-Ling Tsai, Ravi Varadhan, et al.
EJNMMI Research
|
May 22, 2016
Posttreatment FDG PET/CT in predicting survival of patients with ovarian carcinoma
Linda C Chu, Hua-Ling Tsai, Hao Wang, et al.
Cancer
|
December 7, 2018
The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status
Farhoud Faraji, Eleni M Rettig, Hua-Ling Tsai, et al.
Plos One
|
July 11, 2024
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer
Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, et al.
Oral Oncology
|
February 9, 2019
The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers
Margueritta El Asmar, Hua-Ling Tsai, Carole Fakhry, et al.
Page
of 10